<SEC-DOCUMENT>0001437749-24-034317.txt : 20241112
<SEC-HEADER>0001437749-24-034317.hdr.sgml : 20241112
<ACCEPTANCE-DATETIME>20241112073012
ACCESSION NUMBER:		0001437749-24-034317
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241111
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241112
DATE AS OF CHANGE:		20241112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				474671997
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		241443297

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx20241111_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:mbrx="http://www.mbrx.com/20241111"><head>
	<title>mbrx20241111_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 11/11/2024 6:32:26 AM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-235">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-236">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20241111.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-11-11</xbrli:startDate>
<xbrli:endDate>2024-11-11</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-17"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-28"><b>November 11, 2024</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="text-align: center;"><img alt="logo01.jpg" src="logo01.jpg"/></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-35"><b>MOLECULIN BIOTECH, INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-44"><span style="text-transform:uppercase;">Delaware</span></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-48"><b>001-37758</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align: middle; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-52"><b>47-4671997</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of Incorporation</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">or Organization)</div>
			</td>
			<td style="vertical-align: top; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align: top; width: 33%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-65"><b>5300 Memorial Drive</b></ix:nonNumeric>, Suite 950, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-67"><b>Houston</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressStateOrProvince" id="ixv-69"><b>TX</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-71"><b>77007</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-77"><b>713</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-79"><b>300-5160</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 24pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-246">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-247">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-248">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-249">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160; Emerging growth company&#160;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-250">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 0.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-top: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 0.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle" id="ixv-251">Common Stock, par value $.001 per share</ix:nonNumeric></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol" id="ixv-252">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-253">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 2.02</b>&#160;&#160;&#160;&#160;&#160;<b>Results of Operations and Financial Condition.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 11, 2024, Moleculin Biotech, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the quarter ended September 30, 2024 and recent operational highlights. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 </b>&#160;&#160;&#160;&#160;&#160;<b>Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 16pt;text-indent:21pt;">(d)&#160;&#160;&#160;&#160;&#160;Exhibits.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 90%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8%;">&#160;</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 90%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 90%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_745839.htm" style="-sec-extract:exhibit;">Press Release dated November 11, 2024</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8%;">&#160;</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 90%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="vertical-align: top; width: 2%;">&#160;</td>
			<td style="vertical-align: top; width: 90%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Cover page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:&#160;&#160;November 12, 2024</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By: &#160;<span style="text-decoration: underline;">/s/ Jonathan P. Foster</span>&#160;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jonathan P. Foster</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_745839.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_745839.htm</title>
	<!-- Generated by ThunderDome Portal - 11/11/2024 12:37:51 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="cursor: auto; padding: 0in 0.1in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font><img alt="logo01.jpg" src="logo01.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>- On track to start dosing in pivotal, adaptive Phase 3 clinical trial (the </i>&#8220;<i>MIRACLE</i>&#8221;<i> trial) designed for possible accelerated approval of Annamycin in combination with cytarabine for the treatment of R/R AML in Q1 2025</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>- Median durability of CRc in MB-106 Annamycin+ Cytarabine AML clinical trial continues to climb - now past 8 months </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>- Recent virtual AML KOL event underscores how Annamycin could significantly change the AML treatment landscape; </i><u><i>Replay available here</i></u></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><i>- Company to host conference call and webcast today, Monday, November 11</i><i><sup style="vertical-align:top;line-height:120%;">th</sup></i><i> at 8:30 AM ET</i></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>HOUSTON, November 11, 2024 /PRNewswire/ -- Moleculin Biotech, Inc.</b>, (Nasdaq: MBRX) (&#8220;Moleculin&#8221; or the &#8220;Company&#8221;), a late stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today reported its financial results for the quarter ended September 30, 2024. As previously announced, the Company will host a conference call and <u>live audio webcast</u> to discuss the operational and financial results at 8:30 AM ET on Monday, November 11, 2024 (details below).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;We are thrilled to have emerged as a late stage company. Our focus remains on the ramp up for and execution of our upcoming MIRACLE trial. We have been extremely active and our recent interactions with potential clinical trial sites globally have been overwhelmingly positive as we prepare for the start of enrollment and dosing early next year. We believe with our recent clinical and regulatory &#8216;wins,&#8217; we have foundationally set the stage for a transformational year ahead and the opportunity to drive significant value for all stakeholders. With that said, we continue to follow our CRc (complete response composite) preliminary data from our MB-106 Phase 1B/2 AML clinical trial. We are also pleased with the median durability continuing to climb &#8211; and is now in excess of 8 months,&#8221; commented <u>Walter Klemp, Chairman and Chief Executive Officer of Moleculin</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Recent Highlights </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Appointed Daniel D. Von Hoff, M.D., F.A.C.P., FASCO, FAACR, leading expert in Pancreatic Cancer to its Scientific Advisory Board to Support Development of Annamycin;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Hosted a <u>Virtual Acute Myeloid Leukemia KOL event</u>&nbsp;with internationally renowned Acute Myeloid Leukemia (AML) Key Opinion Leaders to discuss Annamycin, the use of anthracyclines, how Annamycin could significantly change the AML treatment landscape, and the Company&#8217;s recently announced global Phase 3 pivotal trial for the treatment of AML patients who are refractory to or relapsed after induction therapy (R/R AML) (the &#8220;MIRACLE&#8221;&nbsp;trial);</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Presented positive <i>in vivo </i>efficacy data of Annamycin in orthotopic and experimental lung metastatic models of Sarcoma in a poster titled &#8220;<u><i>Annamycin: Opening New Doors for Organotropic Targeting of Primary and Metastatic Lung Cancer</i></u><i>,</i>&#8221;<i>&nbsp;</i>at the IASLC 2024 World Conference on Lung Cancer;</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Commenced enrollment and treatment of patients in the Investigator-initiated Phase 2 study evaluating WP1066 in combination with radiation therapy for the treatment of adults with glioblastoma; and</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Closed a $5.5 million financing upfront with up to an additional $11.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Clinical Development Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Annamycin is currently being evaluated in ongoing clinical trials for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. Annamycin currently has Fast Track Status and Orphan Drug Designation from the FDA for the treatment of relapsed or refractory acute myeloid leukemia, in addition to Orphan Drug Designation for the treatment of soft tissue sarcoma. Furthermore, Annamycin has Orphan Drug Designation for the treatment of relapsed or refractory acute myeloid leukemia from the European Medicines Agency (EMA).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>AML </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company recently announced the positive discussion and outcome of its End of Phase 1B/2 (EOP1B/2) meeting with the US Food and Drug Administration (FDA) supporting the advancement of Annamycin in combination with Cytarabine (also known as &#8220;Ara-C&#8221; and for which the combination of Annamycin and Ara-C is referred to as &#8220;AnnAraC&#8221;) to a Phase 3 pivotal trial for the treatment of AML patients who are refractory to or relapsed after induction therapy (R/R AML). This Phase 3 &#8220;MIRACLE&#8221; trial (derived from <b><u>M</u></b>olecul<b><u>i</u></b>n <b><u>R</u></b>/R AML <b><u>A</u></b>nnAraC <b><u>Cl</u></b>inical <b><u>E</u></b>valuation) will be a global trial, including sites in the US.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The MIRACLE study, subject to appropriate future filings with and potential additional feedback from the FDA and their foreign equivalents, is expected to initially utilize an adaptive design whereby approximately the first 75 to 90 subjects will be randomized to receive high dose cytarabine (HiDAC) combined with either placebo, 190 mg/m<sup style="vertical-align:top;line-height:120%;">2</sup> of Annamycin, or 230 mg/m<sup style="vertical-align:top;line-height:120%;">2</sup> of Annamycin. At that point, the trial will be unblinded to select the optimum dose for Annamycin. For the second part of the trial, approximately 240 additional subjects will be randomized to receive either HiDAC plus placebo or HiDAC plus the optimum dose of Annamycin. The selection of the optimum dose will be based not only on the overall balance of safety, tolerability, pharmacokinetics and efficacy, consistent with the FDA&#8217;s new Project Optimus initiative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Expected Milestones for Annamycin AML Development Program </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4Q 2024 &#8211;&nbsp;Contracting with MIRACLE trial sites and IRB approval</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1Q 2025 &#8211;&nbsp;First subject treated in MIRACLE trial</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4Q 2025 &#8211;&nbsp;Recruitment and overall efficacy rate update (n=45)</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2H 2026 &#8211;&nbsp;Interim efficacy and safety data (n=90) unblinded and Optimum Dose set for MIRACLE trial</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2027 &#8211;&nbsp;Begin enrollment of 3<sup style="vertical-align:top;line-height:120%;">rd</sup>&nbsp;line subjects in MIRACLE2</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2027 &#8211;&nbsp;Enrollment ends in 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&nbsp;line subjects</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 &#8211;&nbsp;Primary efficacy data for 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&nbsp;line subjects in MIRACLE</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2028 2H &#8211;&nbsp;Begin submission of a Rolling New Drug Application (NDA) for the treatment of R/R AML for accelerated approval on primary endpoint of CR from MIRACLE</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>STS Lung Metastases </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As previously announced, the Company completed enrollment in the Phase 2 portion of its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases. Subjects who had stable disease at the time of study discontinuation were followed for progression free response and overall survival. The study database is locked, and the clinical study report is being written and should be completed in early 2025 and will be released in detail at that time</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Expected Milestones for Annamycin STS Lung Mets Development Program </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025 &#8211;&nbsp;Final MB-107 data readout</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025 &#8211;&nbsp;Identify next phase of development / pivotal program</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary of Financial Results for the Third Quarter 2024</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development (R&amp;D) expense was $4.9 million and $3.3 million for the three months ended September 30, 2024 and 2023, respectively. The increase over the prior year period is mainly related to costs incurred for clinical trials (clinical research organization and drug production) and sponsored research costs.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">General and administrative expense was $2.2 million and $2.6 million for the three months ended September 30, 2024 and 2023, respectively. The decrease of $0.4 million is mainly related to a decrease in regulatory and legal fees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of September 30, 2024, the Company had cash and cash equivalents of $9.4 million and believes that the existing cash and cash equivalents as of September 30, 2024, will be sufficient to fund planned operations into the first quarter of 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Conference Call and Webcast</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin management will host its quarterly conference call and <u>webcast</u> for investors, analysts, and other interested parties on Monday, November 11, 2024 at 8:30 AM ET.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Interested participants and investors may access the conference call by dialing (877) 407-0832 (domestic) or (201) 689-8433 (international) and referencing the Moleculin Biotech Conference Call. The <u>live audio webcast</u> will be accessible on the <u>Events</u> page of the <u>Investors</u> section of the Moleculin website, <u>moleculin.com</u>, and will be archived for 90 days.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About Moleculin Biotech, Inc.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses. The Company&#8217;s lead program, Annamycin, is a next-generation anthracycline designed to avoid multidrug resistance mechanisms and to eliminate the cardiotoxicity common with currently prescribed anthracyclines. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is initiating the MIRACLE (<b>M</b>olecul<b>i</b>n <b>R</b>/R AML <b>A</b>nnAraC <b>Cl</b>inical <b>E</b>valuation) Trial (MB-108), a pivotal, adaptive design Phase 3 trial evaluating Annamycin in combination with cytarabine, together referred to as AnnAraC, for the treatment of relapsed or refractory acute myeloid leukemia. Following a successful Phase 1B/2 study (MB-106), with input from the FDA, the Company believes it has substantially de-risked the development pathway towards a potential approval for Annamycin for the treatment of AML. This study is subject to appropriate future filings with potential additional feedback from the FDA and their foreign equivalents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For more information about the Company, please visit <u>www.moleculin.com</u> and connect on <u>X</u>, <u>LinkedIn</u> and <u>Facebook</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Forward-Looking Statements </b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the Company's forecasted cash burn rate (including its estimate of cash sufficient to meet its projected operating requirements) and the achievement of the expected milestones set forth above. Although Moleculin believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Moleculin has attempted to identify forward-looking statements by terminology including &#8216;believes,&#8217; &#8216;estimates,&#8217; &#8216;anticipates,&#8217; &#8216;expects,&#8217; &#8216;plans,&#8217; &#8216;projects,&#8217; &#8216;intends,&#8217; &#8216;potential,&#8217; &#8216;may,&#8217; &#8216;could,&#8217; &#8216;might,&#8217; &#8216;will,&#8217; &#8216;should,&#8217; &#8216;approximately&#8217; or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. &#8220;Risk Factors&#8221; in our most recently filed Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) and updated from time to time in our Form 10-Q filings and in our other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. We undertake no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Contact:</b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">JTC Team, LLC</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jenene Thomas</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(908) 824-0775</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>MBRX@jtcir.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 76%; border-top: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Moleculin Biotech, Inc.</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unaudited Condensed Consolidated Balance Sheets</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(in thousands)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>September 30, 2024</b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>December 31, 2023</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">9,405</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">23,550</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Prepaid expenses and other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">2,201</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">2,723</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">11,606</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">26,273</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Furniture and equipment, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">190</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">272</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Intangible assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">11,148</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">11,148</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease right-of-use asset</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">450</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">524</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">23,394</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">38,217</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Current liabilities:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts payable and accrued expenses and other current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,593</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">6,815</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total current liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">5,593</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">6,815</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating lease liability - long-term, net of current portion</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">390</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">474</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Warrant liability - long term</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">9,932</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">4,855</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">15,915</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">12,144</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">7,479</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">26,073</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total liabilities and stockholders' equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">23,394</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">38,217</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 52%; border-top: 1px solid black; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Unaudited Condensed Consolidated Statements of Operations</b></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black;"><b>&nbsp;</b></td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&nbsp;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Three Months Ended September 30,</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Nine Months Ended September 30,</b></p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>(in thousands, except share and per share amounts)</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2024</b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2024</b></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Revenues</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Research and development</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">4,932</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">3,280</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">13,274</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">12,855</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">General and administrative and depreciation and amortization</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">2,203</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">2,667</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">6,724</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">7,857</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Total operating expenses</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">7,135</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">5,947</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">19,998</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">20,712</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss from operations</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(7,135</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(5,947</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(19,998</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(20,712</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Other income:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(Loss) gain from change in fair value of warrant liability</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1,728</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,423</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">76</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Transaction costs allocated to warrant liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(993</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">(993</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">-</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Loss on issuance of warrant liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(847</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(847</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Other income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">9</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">13</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">31</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">30</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Interest income, net</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">102</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">324</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">503</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">1,106</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(10,592</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(5,609</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(19,881</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(19,500</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Net loss per common share - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(2.85</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(2.82</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.4" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(6.83</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.5" style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0); text-align: right;">(9.94</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted average common shares outstanding - basic and diluted</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,714,278</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,987,283</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.4" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,910,842</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.5" style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,961,327</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20241111.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/11/2024 6:32:27 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:mbrx="http://www.mbrx.com/20241111" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20241111">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20241111_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20241111_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20241111_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20241111/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20241111_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/11/2024 6:32:27 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20241111/role/statement-document-and-entity-information" xlink:href="mbrx-20241111.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20241111/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20241111_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/11/2024 6:32:27 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20241111_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 11/11/2024 6:32:27 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20241111/role/statement-document-and-entity-information" xlink:href="mbrx-20241111.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20241111/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M5MJ%_P#V?HT,=L9OLT>HWIN(AJVIS.DEQ.Q,\Z6<5K;VWU3X[_X)/_%WP?\
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M3KG0;.S^Q6W_  D6M)<E);VVTKP_?;)&61?#]U!+J-YQ/[#'_!2CPM_P3Y^
M^D?L;_MA_ OXR_"+XL_":S\3?\(M GAE]?L/BQ)K?BS5_$-K;>&KNS,-M]MF
MNO$,%A::C]JNO"=RD:W!\50SN;9?OS_@G_\ #_X]_$']H_X^_MS_ !N^&T7P
M8TWXV>$O"/ACX??#76+^>^\;:=X9\-)MM]5\2Q/8VB:7+J=O;65Y]AD2VO5O
M+BX2;3[-88)+NO&##9CE6/XARVKPUPYDO!.65Z]'P_JY3# RCCLO]LW@LRPV
M;4,17Q6:U,SP:IXK'XVM7E)XFI)26'G&5&']]\/9YF'"/"7&&;<4<$>'D.&L
M@R!5_"/'YQD^58O&5^-J^+P,,OQF42IU7B^(93P=3'8_,J>.I8O+Z6)PN'JX
MFG1J4E3J^*ZE\$/VF_\ @F:OAVR_9[^)-K\4OA'\6O%&@_#BU\%_%>5WO?"?
MQ3\>7":5I7B73+C2HK9)=*U'5G-[JJVD=JMO"KI?V>I%?[9LOH/2OV//%?@G
MXC?#JTUGXY>.?$6O_%\ZMXA_:"=;M+2V\<ZYX.?3_$.AWVBM&UK)X6TS1==N
M-)\.V\%C'Y=QH4MM89L?/FCDX?\ :P_:'\8?'WQ'H\'[,GPPO/BOX._9,^*.
MB_%CXE>-+F[&C>#]:\3?#^6]$WP_\(W\R!O$6L:<+FXU76+^RCNK736TZVM8
M(=0DNVC;[F\$^*/AM^T=XV^#7CNW7QGHOC7P9\.;'XG+HD#74&AZ7I/Q;T&&
M"U\.>+I[>-]*U#6I+.&VU:WTB.Y-Y9+96>K7<,5K<Z?]K_S^SG)\LSGB#&X+
M$_7*U6AB\JQ6286OC,7A,%2A*LGF4\MJ0:A4=2I"I2K1YYP<>>G3Y:<W?QN,
MN+/$"CPMD'$_$>$R+"\0\09?Q'2\0,TP64Y-+B'&XB&$A6X07%N HWJ8.O3P
ME?#9A@ZL\)A:LYO!XG%*IB*%&1\N_MN?"CXK_$/]IO\ 9BU;P=X&U[7O"?@+
M5_#FK:YX@L+82:;I[W/CK2KS4TN)=ZB*:VL-#AO+G*2*5G@)?Y6#> _\%(?V
M3OBKX\^-FD>._A;X#UGQ99:]X1TZ#7I-%M$ECM-9T:[O+>,W+C:5>?3SIJ*S
MEOEM9%  *A?WJ5.OS,"P;/(! ).,  !<# R "<+DD@4X1J#G&2>O Y.003@#
M)& .>H SD\U\OQI]&[AGCG+^.,OS?.,TA#C?B#*.(J]:C2POM,KQ63858/#X
M? RFG)T9T$XU)5/>>O<_-N!_I'\6< YAP#F&397E$I<!</YYP[A:59XE4\TP
MF>XUYABJN/C"HK5(8IJ=.-)QC[D7)7/Q4\4_LP?$;1O^";WA[X4Z#X-U;5/B
M/JFOZ1XKUOP]:PI_:,=_J/B%M1NH9D+*H:QL#9VK9R4%LJ9/6O4?^"7WP;^)
M7PG\%_%'3/B5X,U?PG-K/B'2+BPM]8@6&2^MX=.NK>9HH_,/RJ[K&Y?C<RG&
M#BOU:\L9SDCO@' )Q@D@<'H.HXP,=!A/*7!&2 1C@@8'.<8 P2"1G[PS\I!
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M"4)F1F7+C^JU4"KMR2.Y)P>IQ]W;T'RYQD@ ,31Y:]@1US@GN<G\R.O7&0"
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LB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45782194935408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Nov. 11,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M%1G)3!BU@V-4B8NK/XP1Q*! #"Y"?.0Q(],L63)518*+N*YWU0J"S@T"=%,
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M;%!+ 0(4 Q0    ( ,4[;%FUP0BM[0   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,4[;%F97)PC$ 8  )PG
M   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ Q3ML6=E:9+I7!   M!   !@              ("!# @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,4[;%F?H!OPL0(  .(,
M   -              "  9D,  !X;"]S='EL97,N>&UL4$L! A0#%     @
MQ3ML69>*NQS     $P(   L              ( !=0\  %]R96QS+RYR96QS
M4$L! A0#%     @ Q3ML63JJHN=  0  / (   \              ( !7A
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,4[;%DD'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( ,4[;%EED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx20241111_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20241111/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mbrx-20241111.xsd</File>
    <File>mbrx-20241111_def.xml</File>
    <File>mbrx-20241111_lab.xml</File>
    <File>mbrx-20241111_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mbrx20241111_8k.htm">mbrx20241111_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mbrx20241111_8k.htm": {
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20241111",
   "dts": {
    "schema": {
     "local": [
      "mbrx-20241111.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mbrx-20241111_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20241111_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20241111_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx20241111_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.mbrx.com/20241111/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20241111_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20241111_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mbrx.com/20241111/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001437749-24-034317-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-034317-xbrl.zip
M4$L#!!0    ( ,4[;%GN))V9#2,  #_" 0 -    97A?-S0U.#,Y+FAT;>U=
M:7O;1I+^//X5O9I,(CT+4CQTT;+UK"S)Q\:R%4F9S+=]FD"3[!A (S@D,[]^
MJ[H;(,!+E,P#)'LFB2020%]O5[U5755XTXL]]^Q-CU'G[-4_WL0\=MD9^_Y_
MQP>')\U6%;Y]LZ\^A&__JU(A'YC/0AHSA[3[Y+Z7^ X++X7'R(T(8^J2"JG7
M]^&?1JUQ0.J-U\WCUX=U<G--*I6S-QZ+*;%[-(Q8_'8GB3N5DQW]J4\]]G:G
M(T*/QA6'Q<R.N?!WB"W\F/EP=<Q<%O2$S][Z8N?LU9M]U><W;>'T213W7;C=
M3L)(A*\)36)Q2@+J.-SOOB8U[I-:M<[]4]*!QU4ZU.-N_S7Y^:]$Q*?WW&,1
M^<(>R:WPJ*\^M(C\V"(1"WE'WQ?QO]EK4J\%\2GV($B;]6C8Y3ZT$WPG^"6)
MV?>X0EW>A0]#WNW%HP^8N2?0U!N\-FVL<-\O0[?\\D2_X5GMLZOO/=[F,6FU
MJO4W^^VS-_MX%?P(SE[-.BJ7=4HTJ)_]=A2<IN/@7I=0%R#CBJZHU:M_!MT=
M$H5VX8.1X>:[,-*#TT&3<J#RSP<:<NK'KWT$K7NJYTNA(^W1Y#:&FLBWT)C0
M0FX!;-@3+,RU2=)_3V3[L,S7PF5VX@+V;UD FS."[<I#A_R6T!#N)7*'ON<^
M]6T.&_>618D+%U'?(3>A>. .=.]"A' K;'?R>^# #P67C9HXG"Q^5B%??1*'
MU/Y&8@&MPA011T0@/@A,8, ?! @WBU"'!C%_ &G7HQ$C36+#_'(;IB\.<1)W
MXQXC;_;YV<__/&DT:J?PY.M/M^<7GZ^R#^OXH;I\C\ <0Z= F(+@(X&((MYV
M&:&V#<).25D:!+ 8\&C1(><^2,F^#1V"?VSAM6'Q4$J21Q[WB-V'7E/XC,FG
M84_BD-'8@Q'CW;?[M^3\^C/>^UL=5_\0^[2AJWG-'+B%. G.B,OC/L[ Q:V-
MH[]^5ZG7C@:S^=_D8C!U.$-#BXHJB/L)=!.@ =]Y;=!ROG@$!1/!?B,>?-^+
MR ;/YBW#K\@##^,$)@3GZ->OGPE[P$\E!8AL$4++/9B5 4IMD;@.083S#LRG
M'[M]U/Y^ETETXF,&"'5!\$0V#=BIFLD$FP;)Y=(^H0^4NQ2W1H^%3$UT,G6R
MYS\1*YO\"^$%U.\C^'H"  =P[, L^#8C@%%7"NQ'UK81C+%P:-\BU\*7/[^(
M!^:U0=;7ZW+2X)\HR?K^P,(88:X[$(O@%(#/*CV&E 4Z7?L7]"'NO=F'F\[T
M P@%R+]NUF#UR-7]4Y@OV3),VF6Y-O],HIAW^D/KT#[[^/7WN_NO7PIS:BD=
MNG]S"ZU%CSQD^T!SR4#QON,"B&S/(I]\NXJZTR*[7VCDT+]>@Q2Z_<\>V=6*
M(KM'ZPBB);C^6F- ?[D'B@CV"VAE4%2PF0)@U!ZU62*7$S6#!(S4"I2T0T$=
M@@R@(UPN4! Z8=(%\/@.1Z4.<@T&RV)4=O DIQ*+BMR7)$X\$2I* 'L_B9"#
M28B14%(*T$\<*$,G(Q&A)A&I OI+<PT&,L(A=RR(U=PU:VKNJN0\(D'('KA(
M(I .U/=% LAV+'G[1382P+D$/QT+?Q 6+FIEFC@P0+T94$3@IG%X9"=1)!\H
M E2KH#*ING&TYP5X$]"M8_:27O==,%- +D6DS5SQN%==I/"7".4PB_!M:W4;
M0</Q#YCJ$(5X" L#"XNBB<+\,X\!D("T1$6 :D16R=<D!&S <L!\>Y3[$<XP
M+DQ(O8" :$+@X,*P[[ =)+<!N JX*PG@(8A0S:>4;JX2Z(ILNLV8#W<!;CV&
M0+(E3<-'X=VA4F <Y0F5EF6DMD<@T+J46KZH]"..&Z/KBC: K)]K V 0/O:8
MBYV!+X"T<=44/)$AE@.<FG0#*"8)8V!^*%Q7:CKLE.:6C(;P#!_Z3?KPNQP.
MH(F#9E7]RW4^ZR#>'[)N A,LPKX4$?6CTT>834O^?GR*/9$][L!N<C3@H2$P
MN]->=54?*9)>/U)VM]H7V!%"T;J6+:EM@[L]\9%'X8X*<< YO4Z H";Z@; E
MX?'?6$^XR M@2#B.N <;*Z(<-O8CRQ@5/@R$$NP>.5#D9[N(%1?L?]R1 :R3
M0@_.,MO#Z07^!9L6Q@WCHJ03"D_>JTF=XN7U=_N-,4Q.3B^N#G4C0: 5N-91
M\XRC]$8XH^XGKE1&_>04@X#&N>&1Y($<D6<SD#&PT"D?M%))#MW'96=23/T!
MABG(D%]=Y@46N>A1#A/ORX==]#CKD"L%?)C?KQV87+@6GIEI!Y1I"Y4S"Y(K
MP]I4$\J/0#1<)!O(GI=J6<:23;9%"!A]NU/;(6!QN=IAE/T=!=1._]9=>N1.
MW(,&@1H]8TIVSE[]X]4__O$F#N$7_.D,/>^DT,/8&;YL#%4KW"DO7]2\_;-U
M=-Q2$X?-S-:]:7V:ZAF:X%1*>TAT%\G /37DFDH5U\[9.8@M+G?>)?4Y<\EE
ME?P;5,I'T>D 2:Y>5BWROGI>O:C>X&_G=Q=?\<?YQ:U%0#@X4D)_!\J FH/<
M %- 5L1M<@&_PLX$F8#TY\[FJ$-@MY)SYX%'*)3?"2!2>,%=(F4GN021[HH@
M-<8S(VED7N$GHN05_$2,&K!N"5@_ KU%ZH1:XM^IH0VJ@)'K/B"'.^0S2[XQ
MC].![8WJ0*V#5&*2WO@#=0\L63RB=VG"<W9!1>Z17UF?? U 3\+.^ RH!Z6=
MI\T94A4E!R, \0NCZP&3ZJ."1:M@'H:_E?&-G+D#;";2#"AO'VAFEOGAM(=.
MD[>Q_B]L-8#)@3^!JO6$9 (AZR AQ"T+8Q9(MEP:("V@'5340+D3R1?Q>2$-
M^F17^]'VE+,OM=\4*]4Z7ZV)\O&9#6XVN-S@-T!H%0_,;(8W_ QVRP-@5_J\
M&#(^V%2*V@X[?$&+] 0,!M2,LI! ,7$$-P#>34!5X3D:4&]44)YPF"OIZ!T-
M@8!2? #%AA'4\D#/2:&K/&U94Z]!&# ?51_.Q:5 !P#NIZ]AE_HB#F4'[C.'
M 31Q ]U 0HZ]NA[TX3/V26G*S&/'SZRB(SP%&3^CRC3Y='[W^4+9UW^($*3(
MQ<#>1P$U>*C96&9CR8UU(0TL5 I#1G9!_&>BGRN/PR?_@<$3NFA$5T#[Q5R>
MMRB%TH#Q)$X?M"P8ME0"_8\;L"^/QIZ\A$ 5:4%)C%5 U)$>)GE+U^6B[<)6
M@2F1MJ0!LP&S!+,K)/L@/QU6#PDT[2*NM)\28)@$G1 /SB6*D@!9"_H/  3:
M??-3O5ZM93<B\#,7%^UV0]9%MUPW%!$Z7H7-F!/!<[0;CGUGH<UA P#,.XDK
M3QWA4;!1A,\JP/6^H<.$AB$,*ZK.@-EU<E+,< IPD?J3\N;<6AR-OW30.0H2
M$3L)0T7$VTP:QTH\XC$ 0,WO"ORPZ'.+QLO"C&9+RIUQ<"H-%4\;*F[14$&1
M'HD.\ 0>10DCD:8VNW?W=WL%"A2QJ)HW1[)N@W G[_&@[%X>]=\!4TG4^<;7
M,  #A5SBR<BE/)57$ETZ&+'[[R_/YS 42Q(QO5MQ\TYL=UQ38T9?)>^3$-6.
M)T*PH :#QJ$^Z^'/6Y)L7JX2H(0,6L$C=QNM07+>!74,EM+5]?EB3T56)PB
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M1JNCI1I_M)3:AK(O&#@H;UO%BN5AL7O[,_6"T\L]&?2%%.,1V-%/!]56EGR
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MWKQ/0I_+K#CYKM^_$BZS^2WBLY'*R$8)E$8)M";Z*HP&,!I@G 8X;ACQ;^R
M8?'_R8^IW^4J\]X0_U++_+I5/S@Q8M^(_;F!QDC^[27^7[-R,:I @41,170J
M2:1UP2I5P5@OHCGE^&&),/,P#B:?AJY4U3P3&(O7/R]!JCGXF"-2#S%&NH3Z
M;29@E$CI;;RY,_;88[NMGJ>/()NP[1R1H($XM.]*$@XV8W\G1?TT6Q.EQRK/
M\IOF+'^Q,%WQR?ZS8 J62*-^7 8E]S*8EDC)+<VRFQZ6;](KYMJ@2:]8W#J:
M] I#N^>5?.9RVN:NK"EJ,M",B#0BTHC(4I&V%8K(<]N&<6-!=]I7A=#QE;*V
M#8Q^:NY!3J0:)\8SXZC+ZL-X3MCWH778FAC89[(1UL>#\5R,KE%JPI%U4I^8
MG6E2$XRQ,&-J@M%UI3]?+I%",KIG;:*42J,@UDD7;(-5-!RDE&J /JD05X F
MQY<JR5P%^9XLK2?P)81<^$9'E%5'-$WZ@M$0ST+,P7$Y@WQ*K!\VWE: IO^@
M84ASED&J%^3+]K95_J]EJ.H/N!=:5JLY,;G)N,#*HF36,B[U!V!Y8)T<EL*H
M67NOU\9;.F.]7L;;53(5-3:_ZM!J379=&&/&&#/C0-.PZ@?&GC'VS(@]HR1_
M% O[6T^XP#RB7V1-CKAODO'6W<+Y@12G8^O@N%5*)6/2\3;2[/D!K#:.K%I)
M2TVM6T;>UML],MZM;-JPW*%N)E^OQ(E0VV*"F7R]3<C7>P4_,12Y\"+[PIOH
MQTO\&3J>:]*\L_X']?;\"4'ZSOK#QIJ_L_[)E_3>Q? #ZUU&&#^BHTW@ O-6
M^\5WU[S5OC3=-F^U7Q:@UZW3"TLW6P:@#\K6Z^F +EUW9P'TNG5: WK=NJT
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M@%[LMX73/WNSWXL]]^S_ 5!+ P04    " #%.VQ9I9:>0@]$  ";10  "@
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M+>!TNY,AJ]SML_)T-IK3QPX,MCL=MM/Z=,FQJS^NZ&3E#?.%8-A@P]76$F0
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MG@SPM/="+@VYN.-7Y5OCF[E#X0SV*\NCG)B/1[=__"2$CS]%,*I+P*0)W)>
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M0R8VMI,*/G".W9*_2_]MZS/Y$RE KY_ABP.57R:[JRTD#0]B]C4(RG^BIU+
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MO[I\=U7?HBX-#8U%70RDXO\W 5!+ P04    " #%.VQ9L<5$A&@#  !O#0
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M!? E&)*P6D&;\*_1$M?)+4S3L(J71)GT+N#2TE9J1.MD57]Q^A-02P,$%
M  @ Q3ML60.\=?39!   YBP  !4   !M8G)X+3(P,C0Q,3$Q7V1E9BYX;6S-
M6EUOXC@4?5]I_T,V^QS2P'1FBX89(=H9H6FGJ##:U;ZL3'(!:QP;.4Z!?[]V
M^"@=8L=0C%(A2.*3ZW/\<7-SU(^?ERGQGH%GF-&.'S6N? ]HS!),IQW_QS#H
M#GO]ON]E M$$$4:AXU/F?_[T^V\?_PB"KT"!(P&)-UYYHUE.$^"W+ 5OP+A
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MYV3C?U!+ 0(4 Q0    ( ,4[;%GN))V9#2,  #_" 0 -              "
M 0    !E>%\W-#4X,SDN:'1M4$L! A0#%     @ Q3ML6:66GD(/1   FT4
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4!08     !P ' +P!   NB@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>mbrx20241111_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20241111.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2024-11-11</startDate>
            <endDate>2024-11-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-235">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-236">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-28">2024-11-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-35">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-44">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-48">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-52">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-65">5300 Memorial Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-67">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-69">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-71">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-77">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-79">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-246">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-247">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-248">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-249">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-250">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20248K" id="ixv-251">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K" id="ixv-252">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K" id="ixv-253">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
